Form 4: Morgan Stanley Co-President Sells Shares Under 10b5-1 Plan

Morgan Stanley Co-President Daniel A. Simkowitz sold 32,968 shares of common stock for approximately $6 million under a pre-arranged 10b5-1 plan.

Summary

• Daniel A. Simkowitz, Co-President of Morgan Stanley, reported the sale of 32,968 shares of Morgan Stanley common stock.
• The transaction occurred on January 30, 2026, at a weighted average price of $182.6108 per share.
• The total value of the shares sold is approximately $6,029,000.
• The sale was executed pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• Following the transaction, Simkowitz directly beneficially owns 357,342.406 shares and indirectly owns 1,794.818 shares through a 401(k) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it's an insider sale, the execution under a 10b5-1 plan suggests a pre-planned liquidity event rather than a reaction to new negative information, thus not significantly impacting sentiment.

Positives

• The sale was conducted under a Rule 10b5-1(c) plan, indicating it was pre-scheduled and not based on immediate, non-public information.

Negatives

• An insider sale, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces management's direct equity stake in the company.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, particularly by high-ranking executives like a Co-President, are routinely monitored by investors for signals regarding management's confidence in the company's future prospects. While this transaction was executed under a 10b5-1 plan, which mitigates concerns about opportunistic selling, it still represents a reduction in direct equity exposure by a key executive in the financial services sector.

Stakeholder Impact

• Shareholders: May interpret the sale as a slight negative, though mitigated by the 10b5-1 plan.

Key Dates

Recommendation

The insider sale by Co-President Daniel A. Simkowitz, while notable, was conducted under a pre-arranged 10b5-1 plan. This suggests a planned liquidity event rather than a signal of declining confidence in Morgan Stanley's future. The transaction itself does not provide new fundamental information to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Morgan Stanley, MS, Insider Sale, Form 4, Daniel Simkowitz, Equity Transaction, 10b5-1 Plan, Financial Services, Investment Banking